We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Preattached Holder Protects Phlebotomists Against Needlestick Injury

By LabMedica International staff writers
Posted on 08 Jun 2010
A push button blood collection set with a preattached holder is now available to protect health care workers from accidental needlestick injuries (NSIs). More...
The ready-to-use product will also prevent reuse of the tube holder.

Needlestick and sharps injuries carry the risk of infections and are an occupational hazard for all healthcare professionals involved in clinical care. The preassembled device saves time by shortening the blood collection process; the preattached holder covers the holder end of the needle, reducing the risk of injury.

The intuitively designed apparatus consists of a large flexible wing flanking the needle, a push button safety mechanism, and tubing that does not kink or coil. This is connected to the single use holder by way of a luer adaptor. The blood collection set is manufactured by Becton, Dickinson and Company (BD; Franklin Lakes, NJ, USA) and is an improved version of the original Vacutainer collection sets. The new product's in-vein activation of the safety device provides split-second protection against NSIs.

Tube holders that are reused have not been disinfected or sterilized, posing unnecessary exposure to blood borne pathogens including human immunodeficiency virus (HIV), hepatitis C virus, and hepatitis B virus. The National Phlebotomy Association (NPA; Landover, MD, USA) recently completed a study on reusable blood tube holders. The study revealed that 99% of holders sampled, were contaminated with blood. This poses an occupational exposure risk to the healthcare worker and an infection-control exposure risk to the patient.

Single-use holders that are preattached to safety-engineered blood collection needles may provide the highest level of infection prevention for the healthcare industry. One hospital reported an 88% reduction in NSIs after adopting the device, with zero NSIs in the final 21 months after implementing the product.

Dr. Ana Stankovic, M.D, Ph.D., M.S.P.H., world VP at BD diagnostics said, "this product virtually eliminates a healthcare worker's exposure to a contaminated needle and reduces the time required to collect blood for diagnostic testing."

Related Links:

Becton, Dickinson and Company
National Phlebotomy Association



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Molecular Diagnostics

view channel
Image: Skin samples from people with a suspected genetic myopathy were examined for confirmation of disease. Brown spots show abnormal protein buildup inside the nuclei of cells (purple), typical of a type of myopathy called oculopharyngodistal myopathy. (Image Credit: Garvan Institute)

Long-Read Sequencing Test Identifies Genetic Causes in Inherited Muscle Disease

Inherited muscle diseases are highly heterogeneous and often progressive, leaving many patients without a molecular diagnosis despite extensive testing. Conventional assays typically target individual... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.